Literature DB >> 19189046

Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.

M H-C Sheng1, K-H W Lau.   

Abstract

Osteoclasts, the primary cell type mediating bone resorption, are multinucleated, giant cells derived from hematopoietic cells of monocyte-macrophage lineage. Osteoclast activity is, in a large part, regulated by protein-tyrosine phosphorylation. While information about functional roles of several protein-tyrosine kinases (PTK), including c-Src, in osteoclastic resorption has been accumulated, little is known about the roles of protein-tyrosine phosphatases (PTPs) in regulation of osteoclast activity. Recent evidence implicates important regulatory roles for four PTPs (SHP-1, cyt-PTP-epsilon, PTP-PEST, and PTPoc) in osteoclasts. Cyt-PTP-epsilon, PTP-PEST, and PTP-oc are positive regulators of osteoclast activity, while SHP-1 is a negative regulator. Of these PTPs in osteoclasts, only PTP-oc is a positive regulator of c-Src PTK through dephosphorylation of the inhibitory phosphotyrosine-527 residue. Although some information about mechanisms of action of these PTPs to regulate osteoclast activity is reviewed in this article, much additional work is required to provide more comprehensive details about their functions in osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189046      PMCID: PMC2711220          DOI: 10.1007/s00018-009-8811-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  141 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption.

Authors:  S M Violette; W Guan; C Bartlett; J A Smith; C Bardelay; E Antoine; R J Rickles; E Mandine; M R van Schravendijk; S E Adams; B A Lynch; W C Shakespeare; M Yang; V A Jacobsen; C S Takeuchi; K J Macek; R S Bohacek; D C Dalgarno; M Weigele; D Lesuisse; T K Sawyer; R Baron
Journal:  Bone       Date:  2001-01       Impact factor: 4.398

3.  Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.

Authors:  S Umeda; W G Beamer; K Takagi; M Naito; S Hayashi; H Yonemitsu; T Yi; L D Shultz
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 4.  The "Gab" in signal transduction.

Authors:  Haihua Gu; Benjamin G Neel
Journal:  Trends Cell Biol       Date:  2003-03       Impact factor: 20.808

Review 5.  Osteocytes, strain detection, bone modeling and remodeling.

Authors:  L E Lanyon
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

6.  A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkappaB and JNK2.

Authors:  Mehran Amoui; Matilda H-C Sheng; Shin-Tai Chen; David J Baylink; K-H William Lau
Journal:  Arch Biochem Biophys       Date:  2007-03-15       Impact factor: 4.013

7.  Targeted deletion of the osteoclast protein-tyrosine phosphatase (PTP-oc) promoter prevents RANKL-mediated osteoclastic differentiation of RAW264.7 cells.

Authors:  Jeannie H Yang; Mehran Amoui; K-H William Lau
Journal:  FEBS Lett       Date:  2007-05-04       Impact factor: 4.124

8.  Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone.

Authors:  Masayuki Shiota; Tatsuya Tanihiro; Yoshimi Nakagawa; Naohito Aoki; Norio Ishida; Koyomi Miyazaki; Axel Ullrich; Hitoshi Miyazaki
Journal:  Mol Endocrinol       Date:  2003-01-23

9.  Molecular cloning and expression of a unique rabbit osteoclastic phosphotyrosyl phosphatase.

Authors:  L W Wu; D J Baylink; K H Lau
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

10.  Regulation of cytochrome c oxidase activity by c-Src in osteoclasts.

Authors:  Tsuyoshi Miyazaki; Lynn Neff; Sakae Tanaka; William C Horne; Roland Baron
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

View more
  5 in total

1.  Conditional Disruption of miR17~92 in Osteoclasts Led to Activation of Osteoclasts and Loss of Trabecular Bone In Part Through Suppression of the miR17-Mediated Downregulation of Protein-Tyrosine Phosphatase-oc in Mice.

Authors:  Kin-Hing William Lau; Virginia M Stiffel; Charles H Rundle; Mehran Amoui; Jordan Tapia; Tyler D White; Matilda H-C Sheng
Journal:  JBMR Plus       Date:  2017-08-01

Review 2.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

Review 3.  Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis.

Authors:  J Chris Gallagher; A J Sai
Journal:  Maturitas       Date:  2010-01-29       Impact factor: 4.342

4.  Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.

Authors:  Eun-Jung Lee; Jung-Lye Kim; Ju-Hyun Gong; Sin-Hye Park; Young-Hee Kang
Journal:  Biomed Res Int       Date:  2015-03-05       Impact factor: 3.411

5.  Aberrant expression of shared master-key genes contributes to the immunopathogenesis in patients with juvenile spondyloarthritis.

Authors:  Lovro Lamot; Fran Borovecki; Lana Tambic Bukovac; Mandica Vidovic; Marija Perica; Kristina Gotovac; Miroslav Harjacek
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.